1 year return (CAGR)
81.20%
Neurogene Inc Exchange (NASDAQ, USD)
NGNE
32.09
-0.32 (-0.99%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
29.31%
5 year return (CAGR)
-26.71%
10 year return (CAGR)
-18.51%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
642.17M
Price/Sales
-
Ent value
556.91M
Price/Book
2.96
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
46.06%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 32.49 |
| Daily high | 33.15 |
| Daily low | 31.86 |
| Daily Volume | 1.39M |
| All-time high | 442.60 |
| 1y analyst estimate | 80.43 |
| Beta | 1.95 |
| EPS (TTM) | -4.93 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| NGNE | S&P500 | |
| Current price drop from All-time high | -92.75% | -2.08% |
| Highest price drop | -98.34% | -56.47% |
| Date of highest drop | 8 Apr 2025 | 9 Mar 2009 |
| Avg drop from high | -68.33% | -10.68% |
| Avg time to new high | 450 days | 12 days |
| Max time to new high | 2790 days | 1805 days |
News
